Australia

Professor László Tabár Joins DetectedX as the Medical Director of Breast Cancer Imaging

DetectedX Bolsters Executive Team with Internationally Renowned Physician, Academic and Educator to Expand Breast Imaging Educational Content on the Company's Radiology Online Learning Platform SYDNEY, Nov. 21, 2022 /PRNewswire/ -- DetectedX, leaders in intelligent interactive educational techno...

2022-11-21 21:00 2282

Accelerating its international development, the APRIL Group establishes an entity in Germany

LYON, France and PARIS, Nov. 17, 2022 /PRNewswire/ -- The APRIL Group, France's leading wholesale insurance broker, is enjoying strong growthacross multiple marketsand now accelerating its international development by setting up APRIL International GmbH. This new entity will help APRIL provide ev...

2022-11-18 09:30 3074

Island to present at World Antiviral Congress 2022

MELBOURNE, Australia, Nov. 15, 2022 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to advise that CEO and Managing Director, DrDavid Foster will present at the World Antiviral Congress 2022 inSan Diego, USA which ...

2022-11-15 21:00 2247

ExpressVPN's protections examined in two new independent audits, by KPMG and Cure53

TORTOLA, British Virgin Islands, Nov. 10, 2022 /PRNewswire/ -- Leading consumer privacy and security company ExpressVPN today publishes two new audits by KPMG and Cure53. The audits underline ExpressVPN's commitment to transparency and delivering to customers privacy and security that they can tr...

2022-11-10 16:00 1685

Enterprise Loyalty Cloud, Antavo, closes €10M Series A giving rise to next-gen omnichannel loyalty programs

The funding will enable the expansion of Antavo's global presence and further development of the best-in-class, no-code loyalty technology for enterprises LONDON, Nov. 9, 2022 /PRNewswire/ -- Enterprise Loyalty Cloud platform, Antavo , has successfully closed its Ser...

2022-11-09 16:00 1892

Symbio launches Carrier Infrastructure as a Service offering for wholesale customers

SYDNEY, Nov. 7, 2022 /PRNewswire/ -- Industry-leading communications software provider Symbio Holdings (ASX: SYM), today announced the launch of Carrier Infrastructure as a Service (CIaaS) – a unified carrier-grade product suite designed to simplify the wholesale customer experience.   Symbio'...

2022-11-08 09:30 1657

Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting

MELBOURNE, Australia and SAN FRANCISCO, Nov. 7, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation fro...

2022-11-07 23:25 2485

Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases

* Research presented today by University of Michigan Medical School highlights FT011's ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data * The research demonstrated that treatment with FT011 results in a remarkable...

2022-11-04 20:00 2387

Microsoft overtakes Amazon in Interbrand's 2022 Best Global Brands Report

- Apple retains top spot as the Top 100 Brands ranking exceeds more than $3 trillion for the first time - a 16% increase since 2021 - Airbnb (#54), Red Bull (#64) and Xiaomi (#84) are new entrants for 2022 - Microsoft (#2), Tesla (#12) and Chanel (#22) see the greatest YoY growth - Nike (#10) en...

2022-11-04 02:24 2716

LiveHire Announced as a Member on Newly Launched AMS Verified

MIAMI, Nov. 3, 2022 /PRNewswire/ -- LiveHire, the globally-leading direct sourcing and total talent platform, announced its membership on the newly launched AMS Verified platform. LiveHire and AMS launched a strategic alliance in 2021 to expand their joint offering to enterprises inNorth America....

2022-11-03 23:03 2219

The future you desire. The life of your dreams. See it, feel it, believe it. Get ready to receive it with LIFEBOARD VR.

SYDNEY, Oct. 26, 2022 /PRNewswire/ -- The first of its kind and totally unique – Lifeboard VR is a ground-breaking new manifestation platform to help users bring to reality their dreams and goals. It's time to enter a fully immersive virtual reality world where you can customize your vision boar...

2022-10-26 21:01 2086

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting

MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...

2022-10-26 19:25 2154

Acting coach of EUPHORIA star Jacob Elordi and other stars launches new book, spills secrets on how to land the role of a lifetime; and working with De Niro, Pacino and Spielberg

SYDNEY, Oct. 25, 2022 /PRNewswire/ -- World-renowned Australian acting coach Les Chantery has written his first book,Life in a Mid-Shot, a bold new approach to screen auditions proven to land actors the part of their dreams. A conversation on set with Al Pacino in 2007 prompted an ah-ha moment fo...

2022-10-26 00:00 2014

BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing

BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing inAustralia, paving the way for the global life sciences company to provide clinical sequencing ...

2022-10-20 15:27 1584

Symbio extends its Asia expansion into Taiwan

SYDNEY, Oct. 19, 2022 /PRNewswire/ -- Symbio Holdings Limited (ASX: SYM), a leading voice communications software provider, today marked the next milestone in itsAsia-Pacific expansion strategy, announcing it will open service availability inTaiwan in 2023. With the Taiwanese Data Centre marke...

2022-10-19 15:35 1312

PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL

* F-18 Pivalate PET shows high uptake regardless of origin of primary tumour * F-18 Pivalate can be used to monitor cerebral metastases * Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake MELBOURNE, A...

2022-10-19 11:12 1134

Australian parcel theft rockets to an all-time high with the second largest rise than any other country globally

* First global report on parcel theft * Over a third of Australians affected by parcel theft or loss in lifetime * One in ten people globally are now reluctant to shop online because of fear of theft * Australia second highest on global list of increasing parcel problems * Sharpest rise a...

2022-10-17 05:00 1415

Top 100 Tech Retail Start-Up, HIVERY, named Exporter of the Year 2022

SYDNEY, Oct. 14, 2022 /PRNewswire/ -- HIVERY, a leader in innovative AI-driven retail assortment strategy simulation & optimization solutions, was announced as a winner of the2022 Premier's NSW Exporter of the Year in recognition of its in...

2022-10-14 14:54 1181

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy

Australia now open for study of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying t...

2022-10-13 22:25 1272

Actinogen Medical Limited (ACW) announces large Xanamem® therapeutic effect in early-stage Alzheimer's Disease (AD) patients

Clinical Dementia Rating Scale - Sum of Boxes effect of 0.6 to 0.8 points observed in patients with elevated pTau biomarker with once daily, 10 mg, oral therapy SYDNEY, Oct. 10, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) today announces positive Phase 2a clinical data from its Alz...

2022-10-10 20:00 1525
1 ... 11121314151617 ... 55